MedPath

The study to evaluate the efficacy and safety of using platelet-rich plasma for treating acne scar in Thailand

Phase 4
Completed
Conditions
Acne scars
PRP, Platelet-rich plasma, Acne scars
Registration Number
TCTR20220518003
Lead Sponsor
Dermatologic Surgery, Dermatology department, Siriraj hospital, Thailand
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
25
Inclusion Criteria

1. Atrophic acne scars grade 3-4 (goodman and baron qualitative grading system)
2. Thais
3. Healthy

Exclusion Criteria

1. pregnant or lactating woman
2. Having severe acnes
3. Having the skin disease around the treated area
4. Using an energy-based device or other interventions around treated area 6 months prior

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Scars improvement Before intervention, every treatment visits, 14 days, 1, 2, 3, and 6 months after the intervention Level of improvement measure from Antera3d,Subject self assessment score Every treatment visits, 14 days, 1, 2, 3, and 6 months after the intervention percentage of Subject self assessment score,Physicians assessment score Every treatment visits, 14 days, 1, 2, 3, and 6 months after the intervention percentage of Physicians assessment score
Secondary Outcome Measures
NameTimeMethod
Pain score immediate after the intervention Visual analogue scale (0-10),Adverse reaction Every treatment visits, 14 days, 1, 2, 3, and 6 months after the intervention Descriptive report
© Copyright 2025. All Rights Reserved by MedPath